PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2026Medicinski Glasnik0 citationsOpen Access

Predictive value of admission biomarkers for mortality and rehospitalization in hypertensive crisis

View Full Paper
EBEmir BečirovićUniversity of ZenicaMBMinela BećirovićUniversity Clinical CentreABAmir BećirovićUniversity Clinical Centre

Key Points

  • The study aims to determine predictors of all-cause mortality and 6-month rehospitalization in patients experiencing a hypertensive crisis.
  • Conducted a prospective observational study involving 210 adult patients with hypertensive crisis.
  • Collected demographic, clinical, therapeutic data, and laboratory parameters at admission.
  • Analyzed inflammatory and metabolic markers, including neutrophil-to-lymphocyte ratio and homocysteine.
  • Performed multivariate logistic regression and ROC curve analyses to identify independent predictors.
  • 10.9% of patients died, and 27.1% were rehospitalized within 6 months.
  • Deceased patients had significantly higher levels of PLR, SII, homocysteine, and uric acid.
  • Multivariate analysis showed homocysteine, uric acid, PLR, SII, chronic kidney disease, and poor treatment adherence as significant mortality predictors.
  • ROC analysis indicated moderate discriminative power for the biomarkers.

Abstract

pstrongAim /strongTo identify predictors of all-cause mortality and 6-month rehospitalisation in patients with hypertensive crisis, focusing on inflammatory indices, metabolic markers measured at admission, and antihypertensive treatment profiles./p pstrongMethods /strongThis prospective observational study included 210 adult patients with hypertensive crisis. Demographic, clinical, and therapeutic data were collected, including data on comorbidities, antihypertensive drug use, and treatment adherence. Laboratory parameters obtained at admission included neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), pan-immune-inflammation value (PIV), homocysteine, and uric acid. Patients were followed for 12 months. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses were conducted to identify independent predictors./p pstrongResults /strongMortality occurred in 10.9% of patients, and 27.1% were rehospitalised within 6 months. Deceased patients exhibited significantly higher levels of PLR (p=0.0329), SII (p=0.0355), homocysteine (p=0.0488), and uric acid (p=0.021). In multivariate analysis, homocysteine (OR=3.55; plt;0.001), uric acid (OR=1.03; p=0.007), PLR (OR=1.04; p=0.047), and SII (OR=1.01; p=0.030) remained independently associated with mortality. Chronic kidney disease (OR=2.15, p=0.012) and poor treatment adherence (OR=1.92; p=0.017) were also significant predictors. ROC analysis demonstrated moderate discriminative power, with AUC values of 0.68 for PLR, 0.66 for SII, 0.65 for homocysteine, and 0.63 for uric acid./p pstrongConclusion/strong Elevated inflammatory indices and metabolic markers, particularly homocysteine and uric acid, were independently associated with increased mortality risk. Additionally, chronic kidney disease and suboptimal adherence to antihypertensive therapy significantly contributed to adverse outcomes. These findings underscore the importance of comprehensive risk assessment and personalised management in this high-risk population./p

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bečirović et al. (2026) studied this question.

synapsesocial.com/papers/69a287e20a974eb0d3c03c45https://doi.org/10.17392/2028-23-01
Ask AI
Helpful
Bookmark
Share
View Full Paper